DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B

被引:42
|
作者
Fu, Yang [1 ]
Ito, Fumiaki [1 ]
Zhang, Gewen [1 ]
Fernandez, Braulio [1 ]
Yang, Hanjing [1 ]
Chen, Xiaojiang S. [1 ,2 ]
机构
[1] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA
[2] Univ So Calif, Norris Comprehens Canc Ctr, Ctr Excellence NanoBiophys, Dept Chem, Los Angeles, CA 90089 USA
基金
美国国家卫生研究院;
关键词
cytosine/methylcytosine (C/mC) selectivity; enzyme engineering; multiple determinants for mC specificity; substrate specificity alteration; zinc (Zn) deaminase; CD4(+) T-CELLS; CRYSTAL-STRUCTURE; CYTIDINE DEAMINASES; STRUCTURAL DETERMINANTS; AID/APOBEC FAMILY; POTENT INHIBITOR; HIV-1; INFECTION; FOREIGN DNA; VIRUS; AID;
D O I
10.1042/BJ20150382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
APOBEC (apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like) is a family of enzymes that deaminates cytosine (C) to uracil (U) on nucleic acid. APOBEC3B (A3B) functions in innate immunity against intrinsic and invading retroelements and viruses. A3B can also induce genomic DNA mutations to cause cancer. A3B contains two cytosine deaminase domains (CD1, CD2), and there are conflicting reports about whether both domains are active. Here we demonstrate that only CD2 of A3B (A3BCD2) has C deamination activity. We also reveal that both A3B and A3BCD2 can deaminate methylcytosine (mC). Guided by structural and functional analysis, we successfully engineered A3BCD2 to gain over two orders of magnitude higher activity for mC deamination. Important determinants that contribute to the activity and selectivity for mC deamination have been identified, which reveals that multiple elements, rather than single ones, contribute to the mC deamination activity and selectivity in A3BCD2 and possibly other APOBECs.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 50 条
  • [21] Determinants of Oligonucleotide Selectivity of APOBEC3B
    Wagner, Jeffrey R.
    Demir, Ozlem
    Carpenter, Michael A.
    Aihara, Hideki
    Harki, Daniel A.
    Harris, Reuben S.
    Amaro, Rommie E.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (05) : 2264 - 2273
  • [22] The mutagenic effects of APOBEC3A and APOBEC3B in urothelial carcinoma
    Sturdivant, Michael S.
    Truong, Andrew S.
    Zhou, Mi
    Damrauer, Jeffrey S.
    Kim, William Y.
    CANCER RESEARCH, 2023, 83 (07)
  • [23] The roles of APOBEC3B in gastric cancer
    Zhang, Jian
    Wei, Wei
    Jin, Hui-Cheng
    Ying, Rong-Chao
    Zhu, A-Kao
    Zhang, Fang-Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5089 - 5096
  • [24] Rationally Designed APOBEC3B Cytosine Base Editors with Improved Specificity
    Jin, Shuai
    Fei, Hongyuan
    Zhu, Zixu
    Luo, Yingfeng
    Liu, Jinxing
    Gao, Shenghan
    Zhang, Feng
    Chen, Yu-Hang
    Wang, Yanpeng
    Gao, Caixia
    MOLECULAR CELL, 2020, 79 (05) : 728 - +
  • [25] The DNA Cytosine Deaminase APOBEC3B (A3B) is Overexpressed and Enzymatically Active in Malignant Melanomas of the Skin
    Argyris, Prokopios
    Naumann, Jordan
    Song, Kyu Young
    Koutlas, Ioannis
    Giubellino, Alessio
    Harris, Reuben S.
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 317 - 317
  • [26] The DNA Cytosine Deaminase APOBEC3B (A3B) is Overexpressed and Enzymatically Active in Malignant Melanomas of the Skin
    Argyris, Prokopios
    Naumann, Jordan
    Song, Kyu Young
    Koutlas, Ioannis
    Giubellino, Alessio
    Harris, Reuben S.
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 317 - 317
  • [27] Mutational impact of APOBEC3A and APOBEC3B in a human cell line
    Carpenter, Michael
    Temiz, Nuri
    Ibrahim, Mahmoud
    Jarvis, Matthew
    Brown, Margaret
    Argyris, Prokopios
    Brown, William
    Yee, Douglas
    Harris, Reuben
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Interactome Analysis of APOBEC3B in Multiple Myeloma
    Kazuma, Yasuhiro
    Shirakawa, Kotaro
    Sarca, Anamaria Daniela
    Horisawa, Yoshihito
    Fukuda, Hirofumi
    Matsui, Hiroyuki
    Yamazaki, Hiroyuki
    Matsumoto, Tadahiko
    Tanabe, Fumiko
    Morishita, Ryo
    Ito, Shinji
    Takaori-Kondo, Akifumi
    BLOOD, 2019, 134
  • [29] APOBEC3B drives mutagenesis in breast cancer
    Harris, R. S.
    CANCER RESEARCH, 2013, 73
  • [30] Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain
    Shi, Ke
    Carpenter, Michael A.
    Kurahashi, Kayo
    Harris, Reuben S.
    Aihara, Hideki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (47) : 28120 - 28130